MannKind Newsroom

Leerink Partners Maintains MannKind(MNKD.US) With Buy Rating, Announces Target Price $9

Moomoo News13:40 ET

RBC Capital Upgrades MannKind(MNKD.US) to Buy Rating, Raises Target Price to $10

Moomoo News13:40 ET

Wells Fargo Initiates MannKind(MNKD.US) With Buy Rating, Announces Target Price $9

Moomoo News13:31 ET

Wells Fargo Initiates Coverage on MannKind With Overweight Rating, $9 Price Target

MT NewswiresDec 20 07:57 ET

MannKind Analyst Ratings

BenzingaDec 19 10:52 ET

Leerink Partners Keeps Their Buy Rating on MannKind (MNKD)

TipRanksDec 18 00:39 ET

Tudor Pickering Holt Downgrades MannKind to Hold From Buy, Adjusts Price Target to $5.50 From $7

MT NewswiresNov 14 12:57 ET

Oppenheimer Maintains MannKind(MNKD.US) With Buy Rating, Maintains Target Price $12

Moomoo NewsNov 12 08:33 ET

MannKind's Growth Momentum and Increased Confidence in Pipeline Elevate Buy Rating

TipRanksNov 11 01:31 ET

RBC Capital Sticks to Its Hold Rating for MannKind (MNKD)

TipRanksNov 8 07:09 ET

Analysts Have Conflicting Sentiments on These Healthcare Companies: Cigna (CI), Hims & Hers Health (HIMS) and MannKind (MNKD)

TipRanksNov 6 03:13 ET

Leerink Partners Initiates MannKind(MNKD.US) With Buy Rating, Announces Target Price $8

Moomoo NewsSep 9 18:31 ET

MannKind Price Target Announced at $8.00/Share by Leerink Partners

Dow JonesSep 9 08:56 ET

MannKind Analyst Ratings

BenzingaAug 28 09:03 ET

Oppenheimer Maintains MannKind(MNKD.US) With Buy Rating, Raises Target Price to $12

Moomoo NewsAug 28 08:33 ET

Oppenheimer Reaffirms Their Buy Rating on MannKind (MNKD)

TipRanksAug 28 08:22 ET

MannKind's Strong Q2 Performance and Promising Pipeline Merit a Buy Rating

TipRanksAug 9 06:04 ET

Analysts Offer Insights on Healthcare Companies: MannKind (MNKD), Envista Holdings (NVST) and Soleno Therapeutics (SLNO)

TipRanksAug 8 08:31 ET

MannKind (MNKD) Gets a Hold From RBC Capital

TipRanksAug 8 08:29 ET

MannKind Analyst Ratings

BenzingaJun 13 13:42 ET